GPX4 and rheumatoid arthritis: Firstly, RA-FLSs proliferate abnormally in response to the elevation of ROS and lipid oxidation, and the GPX4 inhibitor RSL3 specifically scavenges ROS accumulation in the synovial membrane and downregulates the number of FLSs.